aztreonam has been researched along with Leukemia, Myeloid in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mazzariol, A | 1 |
Zuliani, J | 1 |
Fontana, R | 1 |
Cornaglia, G | 1 |
García Sánchez, JE | 1 |
Vazquez López, ML | 1 |
Blazquez de Castro, AM | 1 |
Perez Simon, JA | 1 |
Gutierrez, NG | 1 |
Martin, IT | 1 |
García-Rodríguez, JA | 1 |
2 other studies available for aztreonam and Leukemia, Myeloid
Article | Year |
---|---|
Isolation from blood culture of a Leclercia adecarboxylata strain producing an SHV-12 extended-spectrum beta-lactamase.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactam Resistance; beta-Lactamases | 2003 |
Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports.
Topics: Adult; Aged; Aztreonam; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Multiple; Drug Therapy, | 1997 |